Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Study Design

Type
Randomized Controlled Trial (RCT)
Sample size
n = 24
Population
24 adults (age 25.2±2.7 years; body mass index: 24.9±2.9 kg/m2)
Methods
double-blind, randomized crossover study, two 2-week dietary intervention periods: low-fiber diet (control) or an oat bran (control +102 g oat bran/day) diet
Blinding
Double-blind
Duration
2 weeks
Funding
Unclear
  • Rigorous Journal

Background/objectives

Oat bran shows cholesterol-lowering properties, but its effects on other cardiovascular risk markers are less frequently investigated. This study examined the effects of oat bran on blood lipids, hemostatic factors and energy utilization.

Subjects/methods

A double-blind, randomized crossover study in 24 adults (age 25.2±2.7 years; body mass index: 24.9±2.9 kg/m2), who completed two 2-week dietary intervention periods: low-fiber diet (control) or an oat bran (control +102 g oat bran/day) diet. Fasting blood samples were drawn before and after each period, and 3-day fecal samples were collected during the last week of each period.

Results

Total cholesterol decreased by 14% during the oat bran period compared with 4% during the control period (P<0.001). Non-high-density lipoprotein (HDL) cholesterol decreased by 16% in the oat bran period compared with 3% in the control period (P<0.01), as did total triacylglycerol (21 vs 10%, P<0.05) and very-low-density lipoprotein triacylglycerol 33 vs 9%, P<0.01). Plasminogen activator inhibitor-1 (PAI-1) and factor VII (fVII) levels decreased more during consumption of oat bran compared with the control period (PAI-1: 30 vs 2.3%, P<0.01; fVII: 15 vs 7.6%, <0.001). Fecal volume and dry matter were greater when consuming the oat bran diet compared with the control (P<0.001), and energy excretion was increased by 37% (1014 vs 638 kJ/day, P<0.001); however, changes in body weight did not differ (oat bran:-0.3±0.5 kg; control: 0.0±0.7 kg).

Conclusions

Addition of oat bran (6 g soluble fiber/day) to a low-fiber diet lowered total and non-HDL cholesterol, as well as hemostatic factors, and may affect energy balance through reduced energy utilization.

Research Insights

  • energy excretion was increased by 37% (1014 vs 638 kJ/day, P<0.001)

    Effect
    Neutral
    Effect size
    Small
    Dose
    102 g/day (6 g soluble fiber/day)
  • Fecal volume and dry matter were greater when consuming the oat bran diet compared with the control (P<0.001)

    Effect
    Neutral
    Effect size
    Small
    Dose
    102 g/day (6 g soluble fiber/day)
  • Total cholesterol decreased by 14% during the oat bran period compared with 4% during the control period (P<0.001).

    Effect
    Beneficial
    Effect size
    Large
    Dose
    102 g/day (6 g soluble fiber/day)
  • changes in body weight did not differ (oat bran:-0.3±0.5 kg; control: 0.0±0.7 kg)

    Effect
    Neutral
    Effect size
    Small
    Dose
    102 g/day (6 g soluble fiber/day)
  • factor VII (fVII) levels decreased more ... (fVII: 15 vs 7.6%, <0.001)

    Effect
    Beneficial
    Effect size
    Moderate
    Dose
    102 g/day
  • Non-high-density lipoprotein (HDL) cholesterol decreased by 16% in the oat bran period compared with 3% in the control period (P<0.01)

    Effect
    Beneficial
    Effect size
    Moderate
    Dose
    102 g/day (6 g soluble fiber/day)
  • Plasminogen activator inhibitor-1 (PAI-1) and factor VII (fVII) levels decreased more during consumption of oat bran compared with the control period (PAI-1: 30 vs 2.3%, P<0.01)

    Effect
    Beneficial
    Effect size
    Moderate
    Dose
    102 g/day (6 g soluble fiber/day)
  • total triacylglycerol (21 vs 10%, P<0.05)

    Effect
    Beneficial
    Effect size
    Moderate
    Dose
    102 g/day (6 g soluble fiber/day)
  • total triacylglycerol (21 vs 10%, P<0.05)

    Effect
    Beneficial
    Effect size
    Moderate
    Dose
    102 g/day
  • Plasminogen activator inhibitor-1 (PAI-1) and factor VII (fVII) levels decreased more during consumption of oat bran compared with the control period (PAI-1: 30 vs 2.3%, P<0.01;

    Effect
    Beneficial
    Effect size
    Moderate
    Dose
    102 g/day
  • factor VII (fVII) levels decreased more during consumption of oat bran compared with the control period (fVII: 15 vs 7.6%, <0.001)

    Effect
    Beneficial
    Effect size
    Moderate
    Dose
    102 g/day (6 g soluble fiber/day)
  • very-low-density lipoprotein triacylglycerol 33 vs 9%, P<0.01

    Effect
    Beneficial
    Effect size
    Large
    Dose
    102 g/day
  • very-low-density lipoprotein triacylglycerol 33 vs 9%, P<0.01)

    Effect
    Beneficial
    Effect size
    Moderate
    Dose
    102 g/day (6 g soluble fiber/day)
Back to top